98%
921
2 minutes
20
Objective: This study aimed to explore the relationships between cumulative C-reactive protein-triglyceride-glucose index (cuCTI) and CTI changes and the risk of new-onset cardiovascular disease (CVD) in middle-aged and older Chinese individuals.
Methods: This longitudinal study employed data from the China Health and Retirement Longitudinal Study. To evaluate the association between the cuCTI index and CVD risk, we conducted Cox regression analyses alongside restricted cubic spline (RCS) regression models. The participants were categorized into three groups on the basis of the dynamic changes in the CTI through K-means clustering. Subgroup analysis and sensitivity analysis were performed to confirm the robustness of the results.
Results: A total of 4157 participants were included in the study, of whom 609 (13.5%) were diagnosed with CVD. The incidence risk of CVD increased with increasing cuCTI. In fully adjusted Model 3, the Cox regression results indicated that, compared with those in Q1, participants in Q2 had a significantly greater risk of developing CVD (HR, 1.53 [1.22, 1.92], P < 0.001); similarly, participants in Q3 had a 1.36 [1.07, 1.74] increased risk (P = 0.014). RCS analysis revealed a linear association between cuCTI and the risk of CVD (P < 0.05). K-means clustering identified three groups of CTI trajectory changes. Compared with participants with consistently low CTI levels, those with persistently high and increasing CTI levels had a significantly elevated risk of developing CVD (HR, 1.31 [95% CI 1.01-1.70], P = 0.041). Subgroup and interaction analyses revealed no statistically significant differences across all subgroups (all p > 0.05).
Conclusion: This study revealed that cuCTI and changes in CTI are independently associated with the risk of CVD among middle-aged and elderly individuals with elevated cuCTI levels, particularly those with sustained high CTI levels, exhibited a significantly higher risk of CVD. As a cost-effective and accessible tool, cuCTI may provide supplementary information for assessing CVD risk. Monitoring long-term changes in the CTI and maintaining it at relatively low levels may aid early identification of individuals at high risk for CVD.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12296596 | PMC |
http://dx.doi.org/10.1186/s12933-025-02869-4 | DOI Listing |
Medicine (Baltimore)
September 2025
Department of Emergency, First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Hospital, Hefei, Anhui Province, China.
The C-reactive protein-triglyceride-glucose index (CTI) is becoming a new indicator for the comprehensive evaluation of inflammation and insulin resistance severity. This study aimed to analyze the correlation between CTI and the risk of acute exacerbation in chronic obstructive pulmonary disease (COPD), as well as its influencing factors, and construct and validate a risk prediction nomogram. We selected 447 COPD patients who visited the First People's Hospital of Mengcheng County from January 2020 to May 2024, among whom 266 were acute exacerbation patients.
View Article and Find Full Text PDFBMC Cardiovasc Disord
August 2025
Department of Emergency, Yuhuan Second People's Hospital, Yuhuan, 317605, China.
Background: The C-reactive protein-triglyceride glucose index (CTI) has been associated with stroke risk in prior studies. However, its relevance among individuals with cardiovascular-kidney-metabolic (CKM) syndrome remains uncertain.
Methods: This study included 5767 participants with CKM syndrome stages 0-3 from the China Health and Retirement Longitudinal Study.
Sci Rep
August 2025
Department of Cardiology, The Second Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, China.
Cardiovascular-Kidney-Metabolic (CKM) syndrome, a concept recently introduced by the American Heart Association (AHA), emphasizes the intricate relationships among metabolic, renal, and cardiovascular diseases. The C-reactive protein-triglyceride-glucose index (CTI) has been proposed as an effective biomarker for insulin resistance (IR) and inflammation. Although there is substantial evidence demonstrating an association between the CTI and cardiovascular disease (CVD), its precise role in individuals with CKM syndrome stage 0-3 remains unclear.
View Article and Find Full Text PDFFront Aging Neurosci
July 2025
Tianhua College, Shanghai Normal University, Shanghai, China.
Objective: To investigate the relationships between obesity-related indicators and motor cognitive risk syndrome (MCR), as well as the mediating role of the C-reactive protein triglyceride glucose index (CTI).
Methods: The aim of this study was to provide evidence-based support to optimize MCR screening programs and develop prevention strategies for cognitive impairment in elderly individuals. This study utilized data from the China Health and Retirement Longitudinal Study (CHARLS) in 2015, and 5,665 participants were ultimately included.
BMC Gastroenterol
August 2025
Department of Gastrointestinal Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Background: The C-Reactive protein-triglyceride-glucose index (CTI), a novel composite biomarker integrating inflammation and insulin resistance, has shown promise in predicting metabolic and inflammatory outcomes. However, its association with bowel dysfunction remains unexplored.
Methods: This population-based cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) 2005–2010 cycles.